Ziegler Capital Management »

Y Mabs Therapeutics shares owned by Ziegler Capital Management

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Ziegler Capital Management from 13F filings

Historical chart of Ziegler Capital Management investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Ziegler Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Ziegler Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $577k 36k 16.26

More positions owned by Ziegler Capital Management

Abbott Laboratories Common (ABT)
Microsoft Corp Common (MSFT)
Alphabet Inc Cap Stk Common (GOOGL)
Apple Common (AAPL)
Amazon Common (AMZN)
Nvidia Corp Common (NVDA)
Mastercard Inc Cl A Common (MA)
Meta Platforms Inc Cl Common (META)
Unitedhealth Group Common (UNH)
Home Depot Common (HD)
Eli Lilly & Co Common (LLY)
Coca Cola Common (KO)
Costco Wholesale Corp Common (COST)
Palo Alto Networks In Common (PANW)
Adobe Common (ADBE)

View all positions for Ziegler Capital Management

Top funds holding Y Mabs Therapeutics

Paradigm Biocapital Advisors
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Cormorant Asset Management
Caligan Partners
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Pictet Asset Management Holding SA
Soleus Capital Management
Dimensional Fund Advisors
Northern Trust
Citadel Advisors

View all funds holding Y Mabs Therapeutics